Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating a minor version update on the page. This update likely reflects a backend or content adjustment rather than changes to the main content.SummaryDifference0.0%

- Check17 days agoChange DetectedThe study record now shows termination due to business reasons. It also indicates that results have been posted.SummaryDifference3%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4, indicating a new build/update of the page.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded related topics entries, including a Schizophrenia topic and a MedlinePlus Genetics reference, to improve cross-linking to related topics and genetics resources.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision label was updated to v3.6.4, indicating a small backend/content update to the page.SummaryDifference0.0%

- Check53 days agoChange DetectedTopic tags were updated to remove Schizophrenia and the related topics MedlinePlus Genetics. This change narrows the subject associations presented for the study on this page.SummaryDifference0.1%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.